Hypomethylation of the 14‐3‐3σ promoter leads to increased expression in non‐small cell lung cancer

Authors:

Abstract
The 14‐3‐3 proteins are a set of seven highly conserved proteins that have recently been implicated in having a role in human tumorigenesis. However, the mechanism by which 14‐3‐3 proteins may act in this capacity is not well understood. In this study, we examined the expression of one of the 14‐3‐3 family members, 14‐3‐3σ, since it was shown previously to be aberrantly altered in human tumors. Using quantitative rtPCR and immunohistochemistry, we found that the expression levels of 14‐3‐3σ were elevated in the majority of human non‐small cell lung cancers (NSCLC) we examined. Surprisingly, we found that the 14‐3‐3σ gene was hypomethylated in lung tumors relative to normal lung tissue suggesting that decreased DNA methylation resulted in increased expression of 14‐3‐3σ in NSCLC. We also determined the gene copy number for 14‐3‐3σ in tumor samples and found no significant correlation with elevated mRNA expression. And also no mutations were found in 14‐3‐3σ gene. Overall, our data suggest that misregulated expression of 14‐3‐3σ gene may be due to altered methylation status.

This publication has 35 references indexed in Scilit: